INSIGHTS ON PHARMACEUTICAL PACKAGING

• Low Temperature Storage Containment For Vial And Syringe Systems

  With the growth of advanced therapy medicinal products, there is an increased need for specialized low-temperature packaging solutions, particularly for vials and syringe systems at -50°C to ≤ -130°C.

• FAQs On The Revised EU GMP Annex 1: Volume 1

  The revised GMP Annex 1 guidelines emphasize quality risk management, enhanced environmental monitoring, and data integrity, which aim to minimize contamination and ensure patient safety.

• West Vantage™ Goes Beyond Contract Manufacturing

  Successfully advancing a drug-delivery device to market demands more than technical expertise; it requires coordinated execution, regulatory insight, and the ability to scale without disruption.

• Ensuring Integrity: A Comprehensive Approach To CCI

  Deterministic CCI testing ensures compliance in packaging. Learn how advanced methods like Vacuum Decay, HVLD, and Helium Leak Detection deliver results aligned with USP 1207 and global standards.

• Choosing The Right Pharma CMO: The 3 Cs That Matter Most

  2/27/2026

  Choosing a CMO is a strategic decision that shapes long‑term quality and scalability. Discover how a focused framework helps teams identify partners that can adapt and support growing portfolios.

• Stability Issues Unique To Liquid Injectables And How To Avoid Them

  3/23/2026

  Liquid injectables face stability risks like oxidation, hydrolysis, aggregation, temperature shifts, and packaging effects, requiring early, rigorous formulation and process controls.

• Setup Made Simple With The BioTitan Retention Device

  5/27/2025

  Find out how quick and simple it is to set up an assembly secured with the Thermo Scientific BioTitan Retention Device.

• Supporting GLP-1 And Peptides With Integrated Solutions

  9/30/2025

  Accelerate GLP-1 and peptide therapy development with integrated drug containment, delivery, machinery, and analytics for reliable combination product performance.

• PCI Pharma Services Capabilities Update January 2026: Fill/Finish

  1/27/2026

  Patricia Krainski highlights PCI’s global sterile fill‑finish and lyophilization strengths, showcasing investments that expand capacity, technologies, and integrated solutions for complex biologics, formulations, and lyophilized products.